Add office photos
Employer?
Claim Account for FREE
Boehringer-Ingelheim
3.9
based on 287 Reviews
Company Overview
Company Locations
Working at Boehringer-Ingelheim
Company Summary
Boehringer-Ingelheim is a research-based pharmaceutical firm dedicated to developing innovative therapies for unmet medical needs in human and animal health.
Overall Rating
3.9/5
based on 287 reviews
On-Par with
industry average
Highly rated for
Work-life balance, Company culture, Salary
Critically rated for
Job security, Promotions
Work Policy
Hybrid
58% employees reported
Monday to Saturday
41% employees reported
Flexible timing
84% employees reported
Within city
51% employees reported
View detailed work policy
Top Employees Benefits
Health insurance
21 employees reported
Job/Soft skill training
19 employees reported
Professional degree assistance
4 employees reported
Cafeteria
4 employees reported
View all benefits
About Boehringer-Ingelheim
Founded in1885 (140 yrs old)
India Employee Count501-1k
Global Employee Count10k-50k
HeadquartersIngelheim, Germany
Office Locations
Websiteboehringer-ingelheim.com
Primary Industry
Other Industries
--
Are you managing Boehringer-Ingelheim's employer brand? To edit company information,
claim this page for free
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Managing your company's employer brand?
Claim this Company Page for FREE
Boehringer-Ingelheim Ratings
based on 287 reviews
Overall Rating
3.9/5
How AmbitionBox ratings work?
5
142
4
84
3
28
2
11
1
22
Category Ratings
3.9
Work-life balance
3.8
Company culture
3.8
Salary
3.8
Skill development
3.7
Work satisfaction
3.2
Promotions
3.1
Job security
Boehringer-Ingelheim is rated 3.9 out of 5 stars on AmbitionBox, based on 287 company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Boehringer-Ingelheim
based on 269 reviews
4.1
Rated by 33 Women
Rated 4.0 for Company culture and 3.9 for Work satisfaction
3.9
Rated by 236 Men
Rated 3.9 for Work-life balance and 3.8 for Salary
Work Policy at Boehringer-Ingelheim
based on 29 reviews in last 6 months
Hybrid
58%
Work from office
32%
Permanent work from home
10%
Boehringer-Ingelheim Reviews
Top mentions in Boehringer-Ingelheim Reviews
+ 5 more
Compare Boehringer-Ingelheim with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.9/5 based on 287 reviews | 4.1/5 based on 3.1k reviews | 3.8/5 based on 3.4k reviews | 4.2/5 based on 3.2k reviews |
Highly Rated for | Work-life balance Skill development Salary | Skill development Work-life balance Salary | Job security | Salary Job security Work-life balance |
Critically Rated for | Job security Promotions | Promotions | Promotions | No critically rated category |
Primary Work Policy | Hybrid 58% employees reported | Work from office 52% employees reported | Work from office 91% employees reported | Work from office 78% employees reported |
Rating by Women Employees | 4.1 Good rated by 33 women | 4.0 Good rated by 393 women | 4.0 Good rated by 355 women | 4.1 Good rated by 321 women |
Rating by Men Employees | 3.9 Good rated by 236 men | 4.1 Good rated by 2.5k men | 3.8 Good rated by 2.8k men | 4.2 Good rated by 2.7k men |
Job security | 3.1 Average | 3.8 Good | 4.0 Good | 4.1 Good |
View more
Boehringer-Ingelheim Salaries
Boehringer-Ingelheim salaries have received with an average score of 3.8 out of 5 by 287 employees.
Business Development Manager
(272 salaries)
Unlock
₹4 L/yr - ₹10 L/yr
Area Sales Manager
(64 salaries)
Unlock
₹8.1 L/yr - ₹15.5 L/yr
Senior Business Development Manager
(43 salaries)
Unlock
₹6 L/yr - ₹11 L/yr
Senior Area Sales Manager
(26 salaries)
Unlock
₹12 L/yr - ₹19.2 L/yr
Medical Representative
(23 salaries)
Unlock
₹3 L/yr - ₹9 L/yr
Key Account Manager
(21 salaries)
Unlock
₹4.9 L/yr - ₹15.5 L/yr
BDM
(16 salaries)
Unlock
₹4.4 L/yr - ₹7.5 L/yr
Medical Advisor
(16 salaries)
Unlock
₹11.6 L/yr - ₹21 L/yr
Brand Manager
(11 salaries)
Unlock
₹10 L/yr - ₹22 L/yr
Sr BDM
(11 salaries)
Unlock
₹6.6 L/yr - ₹13 L/yr
Boehringer-Ingelheim Jobs
Popular Designations Boehringer-Ingelheim Hires for
Area Sales Manager
Create job alerts
Popular Skills Boehringer-Ingelheim Hires for
Boehringer-Ingelheim News
Brainomix secures €16.7 milllion to advance its AI imaging technology in healthcare
- Oxford-based Brainomix has secured €16.7 million in a Series C investment round to expand its AI imaging technology in healthcare.
- The investment round was co-led by Parkwalk Advisors, the Boehringer Ingelheim Venture Fund, and Hostplus via the IP Group Hostplus Innovation Fund, along with support from LifeSci Capital.
- Brainomix, a spinout from the University of Oxford, has developed an AI platform called Brainomix 360 Stroke that automates imaging biomarkers to improve diagnosis and treatment decisions for stroke patients. It has been deployed in over 300 hospitals globally.
- The funding will enable Brainomix to expand into the US market, accelerate the development of its AI-powered technology in new areas, and grow its operations and commercial team.
Eu-Startups | 20 Mar, 2025
Mankind Pharma Launches Generic Version Of Empagliflozin Diabetes Medication
- Mankind Pharma has launched a generic version of Empagliflozin, a diabetes medication, in India following the expiration of Boehringer Ingelheim's patent for the drug.
- The generic version is available under the brand names Empaglyde, Empagreat, and Dynaduo, in various strengths (10 mg to 25 mg).
- The launch aims to increase accessibility and affordability, with prices starting at Rs 5.49 for the 10 mg variant and Rs 9.90 for the 25 mg variant.
- Other companies, including Glenmark and Alkem Laboratories, have also introduced generic versions of Empagliflozin in India.
Bloomberg Quint | 12 Mar, 2025
Stocks To Watch: Paytm, HG Infra, Aurobindo Pharma, RIL, Lupin
- Paytm is selling a 5.4% stake in PayPay Corp for Rs 2,300 crore to SoftBank.
- HG Infra Engineering's subsidiary has won an order worth Rs 862 crore from NHAI.
- Lupin has acquired trademarks of three anti-diabetes medications from Boehringer Ingelheim.
- RIL has acquired a 74% stake in Navi Mumbai IIA for Rs 1,628 crore.
Bloomberg Quint | 16 Dec, 2024
Lupin acquires 3 anti-diabetes trademarks from Boehringer Ingelheim
- Lupin acquires 3 anti-diabetes trademarks from Boehringer Ingelheim.
- Trademark rights for Gibtulio, Gibtulio Met, and Ajaduo will be transferred to Lupin by March next year.
- These drugs belong to a novel class of oral anti-diabetic drugs, indicated to improve glycemic control in adults with type 2 diabetes mellitus.
- The acquisition strengthens Lupin's diabetes portfolio, enabling them to provide effective and affordable treatment options to millions across India.
HinduBusinessLine | 14 Dec, 2024
Powered by
Boehringer-Ingelheim Offices
Compare Boehringer-Ingelheim with
GlaxoSmithKline Pharmaceuticals
4.1
Sanofi
4.2
Fresenius Kabi
4.2
Novo Nordisk
4.1
Teva Pharmaceuticals
3.9
AstraZeneca
4.1
Eli Lilly and Company
3.8
Sandoz
3.9
Otsuka Pharmaceutical India Private Limited
4.1
Novartis Healthcare
4.1
Agilent Technologies
4.1
Merck
4.3
Apcer Life Sciences
3.6
Universal Corporation
3.6
MSD Pharmaceuticals
4.1
Abbott Nutrition International
3.9
Roche Diagnostics
3.8
Cardinal Health
4.1
Eversana
3.6
Vertex
3.8
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Boehringer-Ingelheim
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.1k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 1.9k reviews
Sanofi
Biotech & Life sciences, Manufacturing, Analytics & KPO, Pharma
4.2
• 1.2k reviews
Fresenius Kabi
Manufacturing, Analytics & KPO, Pharma
4.2
• 1k reviews
Novo Nordisk
Internet, Pharma
4.1
• 975 reviews
Teva Pharmaceuticals
Healthcare / Pharma, Clinical Research, Pharma
3.9
• 1.2k reviews
AstraZeneca
Biotechnology, Pharma
4.1
• 847 reviews
Eli Lilly and Company
Pharma
3.8
• 444 reviews
Sandoz
Pharma
3.9
• 423 reviews
Otsuka Pharmaceutical India Private Limited
Manufacturing, Pharma
4.1
• 414 reviews
Boehringer-Ingelheim FAQs
When was Boehringer-Ingelheim founded?
Boehringer-Ingelheim was founded in 1885. The company has been operating for 140 years primarily in the Pharma sector.
Where is the Boehringer-Ingelheim headquarters located?
Boehringer-Ingelheim is headquartered in Ingelheim and has an office in Bangalore / Bengaluru
How many employees does Boehringer-Ingelheim have in India?
Boehringer-Ingelheim currently has more than 500+ employees in India. Sales & Business Development department appears to have the highest employee count in Boehringer-Ingelheim based on the number of reviews submitted on AmbitionBox.
Does Boehringer-Ingelheim have good work-life balance?
Boehringer-Ingelheim has a Work-Life Balance Rating of 3.9 out of 5 based on 200+ employee reviews on AmbitionBox. 79% employees rated Boehringer-Ingelheim 4 or above, while 21% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Boehringer-Ingelheim work-life balance reviews for more details
Is Boehringer-Ingelheim good for career growth?
Career growth at Boehringer-Ingelheim is rated as moderate, with a promotions and appraisal rating of 3.2. 21% employees rated Boehringer-Ingelheim 3 or below, while 79% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Boehringer-Ingelheim promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Boehringer-Ingelheim?
Working at Boehringer-Ingelheim comes with several advantages and disadvantages. It is highly rated for work life balance, company culture and salary & benefits. However, it is poorly rated for job security and promotions / appraisal, based on 200+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
